This most recent study is in addition to five clinical trials which found MedCline™ to be an effective treatment in gastroesophageal reflux disease (GERD) patients suffering with nocturnal reflux symptoms. Highlights from these studies include:
• 87% less esophageal acid exposure at night
• 72% reduction in nocturnal GERD symptom scores
• 95% reported an overall improvement in sleep quality
• 75% reported less difficulty with sliding down at night
Abstracts for each of these studies can be viewed at and downloaded from: https://medcline.com/proven-results/.
This most recently publication further demonstrates the ability of the MedCline™ device to treat multiple forms of reflux. Since its inception, clinical studies have been performed with patients suffering with typical GERD, LPR or “silent reflux,” gestational (or pregnancy) reflux, as well post-esophagectomy patients, and post lung transplant patients who are at higher risk of lung rejection due to reflux.Additional MedCline™ studies are scheduled to be presented at national medical conferences later this year.
medcline gerd laryngopharyngeal reflux lpr gastroesophageal reflux disease nocturnal reflux silent reflux gestational reflux post-esophagectomy patients,